カテゴリー： Market Monitor Global, 世界, 医療/バイオ

整形外科用生物製剤製品のグローバル市場展望 2023年-2029年：骨成長促進剤、粘液補給、幹細胞、その他

◆英語タイトル：Orthoapedics Biologics Products Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC16319）

◆商品コード：MMG23DC16319
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月（※2025年版があります。お問い合わせください。）
◆ページ数：63
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の整形外科用生物製剤製品市場規模と予測を収録しています。・世界の整形外科用生物製剤製品市場：売上、2018年-2023年、2024年-2029年
・世界の整形外科用生物製剤製品市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の整形外科用生物製剤製品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「骨成長促進剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

整形外科用生物製剤製品のグローバル主要企業は、Stryker、 Zimmer Biomet、 Smith+Nephew、 Heraeus Holding GmbH、 Invibio Ltd.、 Evonik Industries、 DePuy Synthes、 Globus Medical Inc.、 Orthofixなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、整形外科用生物製剤製品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の整形外科用生物製剤製品市場：タイプ別、2018年-2023年、2024年-2029年
世界の整形外科用生物製剤製品市場：タイプ別市場シェア、2022年
・骨成長促進剤、粘液補給、幹細胞、その他

世界の整形外科用生物製剤製品市場：用途別、2018年-2023年、2024年-2029年
世界の整形外科用生物製剤製品市場：用途別市場シェア、2022年
・病院、整形外科クリニック、外来手術センター

世界の整形外科用生物製剤製品市場：地域・国別、2018年-2023年、2024年-2029年
世界の整形外科用生物製剤製品市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における整形外科用生物製剤製品のグローバル売上、2018年-2023年
・主要企業における整形外科用生物製剤製品のグローバル売上シェア、2022年
・主要企業における整形外科用生物製剤製品のグローバル販売量、2018年-2023年
・主要企業における整形外科用生物製剤製品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Stryker、 Zimmer Biomet、 Smith+Nephew、 Heraeus Holding GmbH、 Invibio Ltd.、 Evonik Industries、 DePuy Synthes、 Globus Medical Inc.、 Orthofix

*************************************************************

・調査・分析レポートの概要
整形外科用生物製剤製品市場の定義
市場セグメント
世界の整形外科用生物製剤製品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の整形外科用生物製剤製品市場規模
世界の整形外科用生物製剤製品市場規模：2022年 VS 2029年
世界の整形外科用生物製剤製品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの整形外科用生物製剤製品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の整形外科用生物製剤製品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：骨成長促進剤、粘液補給、幹細胞、その他
整形外科用生物製剤製品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、整形外科クリニック、外来手術センター
整形外科用生物製剤製品の用途別グローバル売上・予測

・地域別市場分析
地域別整形外科用生物製剤製品市場規模 2022年と2029年
地域別整形外科用生物製剤製品売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Stryker、 Zimmer Biomet、 Smith+Nephew、 Heraeus Holding GmbH、 Invibio Ltd.、 Evonik Industries、 DePuy Synthes、 Globus Medical Inc.、 Orthofix
...

This research report provides a comprehensive analysis of the Orthoapedics Biologics Products market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Orthoapedics Biologics Products market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Orthoapedics Biologics Products, challenges faced by the industry, and potential opportunities for market players.
The global Orthoapedics Biologics Products market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Orthoapedics Biologics Products market presents opportunities for various stakeholders, including Hospital, Orthopedic Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Orthoapedics Biologics Products market. Additionally, the growing consumer demand present avenues for market expansion.
The global Orthoapedics Biologics Products market was valued at US$ 406.5 million in 2022 and is projected to reach US$ 542.1 million by 2029, at a CAGR of 4.3% during the forecast period.
Key Features:
The research report on the Orthoapedics Biologics Products market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Orthoapedics Biologics Products market.
Market Overview: The report provides a comprehensive overview of the Orthoapedics Biologics Products market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Bone Growth Stimulator, Viscosupplementation), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Orthoapedics Biologics Products market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Orthoapedics Biologics Products market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Orthoapedics Biologics Products market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Orthoapedics Biologics Products market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Orthoapedics Biologics Products market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Orthoapedics Biologics Products market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Orthoapedics Biologics Products, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Orthoapedics Biologics Products market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Orthoapedics Biologics Products market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Bone Growth Stimulator
Viscosupplementation
Stem Cell
Others
Market segment by Application
Hospital
Orthopedic Clinic
Ambulatory Surgery Center
Global Orthoapedics Biologics Products Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Stryker
Zimmer Biomet
Smith+Nephew
Heraeus Holding GmbH
Invibio Ltd.
Evonik Industries
DePuy Synthes
Globus Medical Inc.
Orthofix
Outline of Major Chapters:
Chapter 1: Introduces the definition of Orthoapedics Biologics Products, market overview.
Chapter 2: Global Orthoapedics Biologics Products market size in revenue.
Chapter 3: Detailed analysis of Orthoapedics Biologics Products company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Orthoapedics Biologics Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Orthoapedics Biologics Products Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Orthoapedics Biologics Products Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Orthoapedics Biologics Products Overall Market Size
2.1 Global Orthoapedics Biologics Products Market Size: 2022 VS 2029
2.2 Global Orthoapedics Biologics Products Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Orthoapedics Biologics Products Players in Global Market
3.2 Top Global Orthoapedics Biologics Products Companies Ranked by Revenue
3.3 Global Orthoapedics Biologics Products Revenue by Companies
3.4 Top 3 and Top 5 Orthoapedics Biologics Products Companies in Global Market, by Revenue in 2022
3.5 Global Companies Orthoapedics Biologics Products Product Type
3.6 Tier 1, Tier 2 and Tier 3 Orthoapedics Biologics Products Players in Global Market
3.6.1 List of Global Tier 1 Orthoapedics Biologics Products Companies
3.6.2 List of Global Tier 2 and Tier 3 Orthoapedics Biologics Products Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Orthoapedics Biologics Products Market Size Markets, 2022 & 2029
4.1.2 Bone Growth Stimulator
4.1.3 Viscosupplementation
4.1.4 Stem Cell
4.1.5 Others
4.2 By Type – Global Orthoapedics Biologics Products Revenue & Forecasts
4.2.1 By Type – Global Orthoapedics Biologics Products Revenue, 2018-2023
4.2.2 By Type – Global Orthoapedics Biologics Products Revenue, 2024-2029
4.2.3 By Type – Global Orthoapedics Biologics Products Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Orthoapedics Biologics Products Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Orthopedic Clinic
5.1.4 Ambulatory Surgery Center
5.2 By Application – Global Orthoapedics Biologics Products Revenue & Forecasts
5.2.1 By Application – Global Orthoapedics Biologics Products Revenue, 2018-2023
5.2.2 By Application – Global Orthoapedics Biologics Products Revenue, 2024-2029
5.2.3 By Application – Global Orthoapedics Biologics Products Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Orthoapedics Biologics Products Market Size, 2022 & 2029
6.2 By Region – Global Orthoapedics Biologics Products Revenue & Forecasts
6.2.1 By Region – Global Orthoapedics Biologics Products Revenue, 2018-2023
6.2.2 By Region – Global Orthoapedics Biologics Products Revenue, 2024-2029
6.2.3 By Region – Global Orthoapedics Biologics Products Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Orthoapedics Biologics Products Revenue, 2018-2029
6.3.2 US Orthoapedics Biologics Products Market Size, 2018-2029
6.3.3 Canada Orthoapedics Biologics Products Market Size, 2018-2029
6.3.4 Mexico Orthoapedics Biologics Products Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Orthoapedics Biologics Products Revenue, 2018-2029
6.4.2 Germany Orthoapedics Biologics Products Market Size, 2018-2029
6.4.3 France Orthoapedics Biologics Products Market Size, 2018-2029
6.4.4 U.K. Orthoapedics Biologics Products Market Size, 2018-2029
6.4.5 Italy Orthoapedics Biologics Products Market Size, 2018-2029
6.4.6 Russia Orthoapedics Biologics Products Market Size, 2018-2029
6.4.7 Nordic Countries Orthoapedics Biologics Products Market Size, 2018-2029
6.4.8 Benelux Orthoapedics Biologics Products Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Orthoapedics Biologics Products Revenue, 2018-2029
6.5.2 China Orthoapedics Biologics Products Market Size, 2018-2029
6.5.3 Japan Orthoapedics Biologics Products Market Size, 2018-2029
6.5.4 South Korea Orthoapedics Biologics Products Market Size, 2018-2029
6.5.5 Southeast Asia Orthoapedics Biologics Products Market Size, 2018-2029
6.5.6 India Orthoapedics Biologics Products Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Orthoapedics Biologics Products Revenue, 2018-2029
6.6.2 Brazil Orthoapedics Biologics Products Market Size, 2018-2029
6.6.3 Argentina Orthoapedics Biologics Products Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Orthoapedics Biologics Products Revenue, 2018-2029
6.7.2 Turkey Orthoapedics Biologics Products Market Size, 2018-2029
6.7.3 Israel Orthoapedics Biologics Products Market Size, 2018-2029
6.7.4 Saudi Arabia Orthoapedics Biologics Products Market Size, 2018-2029
6.7.5 UAE Orthoapedics Biologics Products Market Size, 2018-2029
7 Orthoapedics Biologics Products Companies Profiles
7.1 Stryker
7.1.1 Stryker Company Summary
7.1.2 Stryker Business Overview
7.1.3 Stryker Orthoapedics Biologics Products Major Product Offerings
7.1.4 Stryker Orthoapedics Biologics Products Revenue in Global Market (2018-2023)
7.1.5 Stryker Key News & Latest Developments
7.2 Zimmer Biomet
7.2.1 Zimmer Biomet Company Summary
7.2.2 Zimmer Biomet Business Overview
7.2.3 Zimmer Biomet Orthoapedics Biologics Products Major Product Offerings
7.2.4 Zimmer Biomet Orthoapedics Biologics Products Revenue in Global Market (2018-2023)
7.2.5 Zimmer Biomet Key News & Latest Developments
7.3 Smith+Nephew
7.3.1 Smith+Nephew Company Summary
7.3.2 Smith+Nephew Business Overview
7.3.3 Smith+Nephew Orthoapedics Biologics Products Major Product Offerings
7.3.4 Smith+Nephew Orthoapedics Biologics Products Revenue in Global Market (2018-2023)
7.3.5 Smith+Nephew Key News & Latest Developments
7.4 Heraeus Holding GmbH
7.4.1 Heraeus Holding GmbH Company Summary
7.4.2 Heraeus Holding GmbH Business Overview
7.4.3 Heraeus Holding GmbH Orthoapedics Biologics Products Major Product Offerings
7.4.4 Heraeus Holding GmbH Orthoapedics Biologics Products Revenue in Global Market (2018-2023)
7.4.5 Heraeus Holding GmbH Key News & Latest Developments
7.5 Invibio Ltd.
7.5.1 Invibio Ltd. Company Summary
7.5.2 Invibio Ltd. Business Overview
7.5.3 Invibio Ltd. Orthoapedics Biologics Products Major Product Offerings
7.5.4 Invibio Ltd. Orthoapedics Biologics Products Revenue in Global Market (2018-2023)
7.5.5 Invibio Ltd. Key News & Latest Developments
7.6 Evonik Industries
7.6.1 Evonik Industries Company Summary
7.6.2 Evonik Industries Business Overview
7.6.3 Evonik Industries Orthoapedics Biologics Products Major Product Offerings
7.6.4 Evonik Industries Orthoapedics Biologics Products Revenue in Global Market (2018-2023)
7.6.5 Evonik Industries Key News & Latest Developments
7.7 DePuy Synthes
7.7.1 DePuy Synthes Company Summary
7.7.2 DePuy Synthes Business Overview
7.7.3 DePuy Synthes Orthoapedics Biologics Products Major Product Offerings
7.7.4 DePuy Synthes Orthoapedics Biologics Products Revenue in Global Market (2018-2023)
7.7.5 DePuy Synthes Key News & Latest Developments
7.8 Globus Medical Inc.
7.8.1 Globus Medical Inc. Company Summary
7.8.2 Globus Medical Inc. Business Overview
7.8.3 Globus Medical Inc. Orthoapedics Biologics Products Major Product Offerings
7.8.4 Globus Medical Inc. Orthoapedics Biologics Products Revenue in Global Market (2018-2023)
7.8.5 Globus Medical Inc. Key News & Latest Developments
7.9 Orthofix
7.9.1 Orthofix Company Summary
7.9.2 Orthofix Business Overview
7.9.3 Orthofix Orthoapedics Biologics Products Major Product Offerings
7.9.4 Orthofix Orthoapedics Biologics Products Revenue in Global Market (2018-2023)
7.9.5 Orthofix Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Orthoapedics Biologics Products Market Opportunities & Trends in Global Market
Table 2. Orthoapedics Biologics Products Market Drivers in Global Market
Table 3. Orthoapedics Biologics Products Market Restraints in Global Market
Table 4. Key Players of Orthoapedics Biologics Products in Global Market
Table 5. Top Orthoapedics Biologics Products Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Orthoapedics Biologics Products Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Orthoapedics Biologics Products Revenue Share by Companies, 2018-2023
Table 8. Global Companies Orthoapedics Biologics Products Product Type
Table 9. List of Global Tier 1 Orthoapedics Biologics Products Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Orthoapedics Biologics Products Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Orthoapedics Biologics Products Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Orthoapedics Biologics Products Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Orthoapedics Biologics Products Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Orthoapedics Biologics Products Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Orthoapedics Biologics Products Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Orthoapedics Biologics Products Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Orthoapedics Biologics Products Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Orthoapedics Biologics Products Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Orthoapedics Biologics Products Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Orthoapedics Biologics Products Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Orthoapedics Biologics Products Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Orthoapedics Biologics Products Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Orthoapedics Biologics Products Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Orthoapedics Biologics Products Revenue, (US$, Mn), 2024-2029
Table 30. Stryker Company Summary
Table 31. Stryker Orthoapedics Biologics Products Product Offerings
Table 32. Stryker Orthoapedics Biologics Products Revenue (US$, Mn) & (2018-2023)
Table 33. Stryker Key News & Latest Developments
Table 34. Zimmer Biomet Company Summary
Table 35. Zimmer Biomet Orthoapedics Biologics Products Product Offerings
Table 36. Zimmer Biomet Orthoapedics Biologics Products Revenue (US$, Mn) & (2018-2023)
Table 37. Zimmer Biomet Key News & Latest Developments
Table 38. Smith+Nephew Company Summary
Table 39. Smith+Nephew Orthoapedics Biologics Products Product Offerings
Table 40. Smith+Nephew Orthoapedics Biologics Products Revenue (US$, Mn) & (2018-2023)
Table 41. Smith+Nephew Key News & Latest Developments
Table 42. Heraeus Holding GmbH Company Summary
Table 43. Heraeus Holding GmbH Orthoapedics Biologics Products Product Offerings
Table 44. Heraeus Holding GmbH Orthoapedics Biologics Products Revenue (US$, Mn) & (2018-2023)
Table 45. Heraeus Holding GmbH Key News & Latest Developments
Table 46. Invibio Ltd. Company Summary
Table 47. Invibio Ltd. Orthoapedics Biologics Products Product Offerings
Table 48. Invibio Ltd. Orthoapedics Biologics Products Revenue (US$, Mn) & (2018-2023)
Table 49. Invibio Ltd. Key News & Latest Developments
Table 50. Evonik Industries Company Summary
Table 51. Evonik Industries Orthoapedics Biologics Products Product Offerings
Table 52. Evonik Industries Orthoapedics Biologics Products Revenue (US$, Mn) & (2018-2023)
Table 53. Evonik Industries Key News & Latest Developments
Table 54. DePuy Synthes Company Summary
Table 55. DePuy Synthes Orthoapedics Biologics Products Product Offerings
Table 56. DePuy Synthes Orthoapedics Biologics Products Revenue (US$, Mn) & (2018-2023)
Table 57. DePuy Synthes Key News & Latest Developments
Table 58. Globus Medical Inc. Company Summary
Table 59. Globus Medical Inc. Orthoapedics Biologics Products Product Offerings
Table 60. Globus Medical Inc. Orthoapedics Biologics Products Revenue (US$, Mn) & (2018-2023)
Table 61. Globus Medical Inc. Key News & Latest Developments
Table 62. Orthofix Company Summary
Table 63. Orthofix Orthoapedics Biologics Products Product Offerings
Table 64. Orthofix Orthoapedics Biologics Products Revenue (US$, Mn) & (2018-2023)
Table 65. Orthofix Key News & Latest Developments
List of Figures
Figure 1. Orthoapedics Biologics Products Segment by Type in 2022
Figure 2. Orthoapedics Biologics Products Segment by Application in 2022
Figure 3. Global Orthoapedics Biologics Products Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Orthoapedics Biologics Products Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Orthoapedics Biologics Products Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Orthoapedics Biologics Products Revenue in 2022
Figure 8. By Type - Global Orthoapedics Biologics Products Revenue Market Share, 2018-2029
Figure 9. By Application - Global Orthoapedics Biologics Products Revenue Market Share, 2018-2029
Figure 10. By Type - Global Orthoapedics Biologics Products Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Orthoapedics Biologics Products Revenue Market Share, 2018-2029
Figure 12. By Application - Global Orthoapedics Biologics Products Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Orthoapedics Biologics Products Revenue Market Share, 2018-2029
Figure 14. By Region - Global Orthoapedics Biologics Products Revenue Market Share, 2018-2029
Figure 15. By Country - North America Orthoapedics Biologics Products Revenue Market Share, 2018-2029
Figure 16. US Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Orthoapedics Biologics Products Revenue Market Share, 2018-2029
Figure 20. Germany Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 21. France Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Orthoapedics Biologics Products Revenue Market Share, 2018-2029
Figure 28. China Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 32. India Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Orthoapedics Biologics Products Revenue Market Share, 2018-2029
Figure 34. Brazil Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Orthoapedics Biologics Products Revenue Market Share, 2018-2029
Figure 37. Turkey Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Orthoapedics Biologics Products Revenue, (US$, Mn), 2018-2029
Figure 41. Stryker Orthoapedics Biologics Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Zimmer Biomet Orthoapedics Biologics Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Smith+Nephew Orthoapedics Biologics Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Heraeus Holding GmbH Orthoapedics Biologics Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Invibio Ltd. Orthoapedics Biologics Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Evonik Industries Orthoapedics Biologics Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. DePuy Synthes Orthoapedics Biologics Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Globus Medical Inc. Orthoapedics Biologics Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Orthofix Orthoapedics Biologics Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

※参考情報

整形外科用生物製剤製品についての概念は、近年の医療技術の進歩に伴い、多くの研究と開発が行われてきました。生物製剤は、血液や細胞、組織、またはそれらから得られた成分を利用して作られる医療製品であり、整形外科においては主に骨や軟骨の治療に使用されます。この製品群は、外科手術における患者の回復促進や、再生医療の一環として新たな治療法を提供する重要な役割を果たしています。

整形外科用生物製剤の特徴として、自然由来の材料を使用することがあります。これにより、副作用のリスクが低減し、体内の反応も自然なものとなる場合が多いです。例えば、骨移植に用いる生物製剤は、ドナーから採取した骨の組織や、人工的に生成された骨材料を基にしています。これらは、患者の体内で新しい骨組織が生成されるための基盤を提供します。また、生物製剤は、免疫系の反応を抑制する成分を含むことが多く、これにより異物に対する拒絶反応が起きにくくなります。

生物製剤の種類は多岐にわたりますが、整形外科の分野では特に以下のような製品が注目されています。まずは、成長因子を含む生物製剤です。これらは細胞の増殖や分化を促進する物質で、骨や軟骨の再生を誘導します。具体的には、骨形成因子や血小板由来成長因子（PDGF）、骨芽細胞成長因子（BMP）などがあります。これらの成長因子は、外用や注射によって直接患部に送達されることが多く、特に骨折や関節損傷の治療に効果を示しています。

次に、幹細胞を用いた生物製剤があります。幹細胞は、自己再生能力と多分化能を持っており、これらを用いることで、損傷した組織の修復や再生を図ることができます。特に、脂肪由来幹細胞や骨髄由来幹細胞が整形外科領域での研究が進められています。幹細胞を投与することで、異常な細胞環境を改善し、組織再生を助ける仕組みが期待されています。

さらに、合成材料を使用した生物製剤も存在します。これには、バイオマテリアルと呼ばれる天然または合成の高分子材料が含まれます。これらの材料は、組織工学において基盤材料として使われ、細胞の移植や再生を促進する役割を果たします。ポリ乳酸やコラーゲン、ヒアルロン酸などが代表的な材料として利用されています。

整形外科用生物製剤の用途は広範で、特に骨折治療や関節リプレースメント手術、靭帯・腱の修復などで頻繁に使用されます。骨折治療に関しては、従来の治療法と比べて早期回復が見込まれるため、多くの患者にとって有用です。特に難治性骨折や骨折の癒合不良において、再生因子や幹細胞を用いた治療が効果を上げています。また、関節リプレースメント手術においても、患者の自己組織を用いた再生医療が取り入れられることで、手術後のリハビリテーション期間が短縮される可能性が高まっています。

関連技術として、組織工学やナノテクノロジーも挙げられます。組織工学は、細胞、成長因子、そして適切なマトリックス（基盤材料）を組み合わせ、体外で新しい組織を構成する技術です。このアプローチにより、より効率的かつ患者に優しい治療法が提供されることが期待されています。また、ナノテクノロジーは、材料の特性を改善し、細胞との相互作用を強化するために利用されています。これにより、治療効果の向上が図られ、新たな生物製剤の開発が進められています。

整形外科用生物製剤の研究は日々進展しており、今後ますます多様な治療法や製品が登場することが予想されます。しかし、これらを臨床現場で安全かつ効果的に利用するためには、さらなる研究と臨床試験が必要です。生物製剤には未解決の課題も多く、長期的な安全性や効果に関するデータが求められています。医療現場では、これらの情報を基にした適切な使用方法を確立することが重要です。

整形外科用生物製剤は、今後の医療の進展に大きな影響を与える可能性を秘めており、医療従事者や研究者はこの分野の発展に注目し続けることが求められます。患者にとって、より良い治療法の提供が実現されることで、生活の質の向上が期待されるでしょう。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 整形外科用生物製剤製品のグローバル市場展望 2023年-2029年：骨成長促進剤、粘液補給、幹細胞、その他(Orthoapedics Biologics Products Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

整形外科用生物製剤製品のグローバル市場展望 2023年-2029年：骨成長促進剤、粘液補給、幹細胞、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp